[Federal Register Volume 59, Number 181 (Tuesday, September 20, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-23237]
[[Page Unknown]]
[Federal Register: September 20, 1994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Controlled Substances: Established 1994 Aggregate Production
Quota
AGENCY: Drug Enforcement Administration (DEA), Justice.
ACTION: Notice of established 1994 aggregate production quota.
-----------------------------------------------------------------------
SUMMARY: This notice establishes a 1994 aggregate production quota for
3,4-methylenedioxy-N-ethylamphetamine, a substance in Schedule I of the
Controlled Substances Act (CSA).
EFFECTIVE DATE: This order is effective upon September 20, 1994.
FOR FURTHER INFORMATION CONTACT:
Howard McClain, Jr., Chief, Drug & Chemical Evaluation Section, Drug
Enforcement Administration, Washington, DC 20537, telephone: (202) 307-
7183.
SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances Act
(21 U.S.C. 826) requires that the Attorney General establish aggregate
production quotas for all controlled substances in Schedules I and II
each year. This responsibility has been delegated to the Administrator
of the DEA pursuant to Sec. 0.100 of Title 28 of the Code of Federal
Regulations. The Administrator, in turn, has redelegated this function
to the Deputy Administrator pursuant to 59 FR 23637 (May 6, 1994).
On July 19, 1994, a notice of the proposed 1994 aggregate
production quota for 3,4-methylenedioxy-N-ethylamphetamine, a Schedule
I controlled substance, was published in the Federal Register (59 FR
36784). All interested persons were invited to comment on or object to
this proposed aggregate production quota on or before August 18, 1994.
No comments or objections were received.
The Office of Management and Budget has determined that notices of
aggregate production quotas are not subject to centralized review under
Executive Order 12866. This action has been analyzed in accordance with
the principles and criteria contained in Executive Order 12612, and it
has been determined that this matter does not have sufficient
federalism implications to warrant the preparation of a Federalism
Assessment.
The Deputy Administrator hereby certifies that this action will
have no significant impact upon small entities whose interests must be
considered under the Regulatory Flexibility Act, 5 U.S.C. 601, et seq.
The establishment of annual aggregate production quotas for Schedules I
and II controlled substances is mandated by law and by international
treaty obligations. While aggregate production quotas are of primary
importance to large manufacturers, their impact upon small entities is
neither negative nor beneficial. Accordingly, the Deputy Administrator
has determined that this action does not require a regulatory
flexibility analysis.
Therefore, under the authority vested in the Attorney General by
Section 306 of the Controlled Substances Act of 1970 (21 U.S.C. 826),
delegated to the Administrator of the DEA by Sec. 0.100 of Title 28 of
the Code of Federal Regulations, and redelegated to the Deputy
Administrator, pursuant to 59 FR 23637 (May 6, 1994), the Deputy
Administrator hereby orders that the 1994 aggregate production quota
for the following controlled substance, expressed in grams of anhydrous
base, be established as follows:
------------------------------------------------------------------------
Established
Basic class 1994 quota
(in grams)
------------------------------------------------------------------------
3,4-Methylenedioxy-N-ethylamphetamine...................... 5
------------------------------------------------------------------------
Dated: September 13, 1994.
Stephen H. Greene,
Deputy Administrator.
[FR Doc. 94-23237 Filed 9-19-94; 8:45 am]
BILLING CODE 4410-09-M
